Display options
Share it on

Case Rep Oncol. 2014 Dec 09;7(3):825-7. doi: 10.1159/000370106. eCollection 2014.

Hepatocellular carcinoma in a noncirrhotic liver after long-term use of danazol for hereditary angioedema.

Case reports in oncology

Soraya Rahal, Marine Gilabert, Pauline Ries, Sandrine Oziel-Taieb, Slimane Dermeche, Jean-Luc Raoul

Affiliations

  1. Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France.

PMID: 25606032 PMCID: PMC4296231 DOI: 10.1159/000370106

Abstract

We report a 57-year-old male who was treated with high-dose danazol for hereditary angioedema for more than 30 years; he developed hepatocellular carcinoma in the absence of cirrhosis. Despite surgical resection, he had a recurrence and received sorafenib, but had a poor skin tolerance. Such tumors arising after danazol are infrequent, and this case is highly unique due to the minor lesions found on the liver.

Keywords: Danazol; Drug-induced cancer; Healthy liver; Hepatocellular carcinoma

References

  1. Am J Hematol. 2004 Nov;77(3):257-67 - PubMed
  2. Allergy Asthma Proc. 2013 Nov-Dec;34(6):519-22 - PubMed
  3. J Hepatol. 2013 Jan;58(1):81-8 - PubMed
  4. Lancet. 1975 Feb 22;1(7904):430-2 - PubMed
  5. Lancet. 1999 Mar 27;353(9158):1066-7 - PubMed
  6. Acta Derm Venereol. 2006;86(3):272-3 - PubMed
  7. QJM. 2003 Apr;96(4):317-8 - PubMed

Publication Types